Drug Type TCR therapy |
Synonyms |
Target |
Mechanism MR1 inhibitors(major histocompatibility complex, class I-related inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization Ervaxx Ltd.Startup |
Active Organization- |
Inactive Organization Ervaxx Ltd.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |